Brief: Moleculin Announces Positive In Vivo Efficacy Data Of Annamycin In Orthotopic And Experimental Lung Metastatic Models Of Sarcoma

Moleculin Biotech

23/09/2024 14:24

Sept 23 (Reuters) - Moleculin Biotech Inc  MBRX.O :
    * MOLECULIN ANNOUNCES POSITIVE IN VIVO EFFICACY DATA OF
ANNAMYCIN
IN ORTHOTOPIC AND EXPERIMENTAL LUNG METASTATIC MODELS OF SARCOMA
    * MOLECULIN BIOTECH INC - ANNAMYCIN SHOWS SIGNIFICANT
INHIBITION
OF TUMOR GROWTH IN LUNG CANCER MODELS
    * MOLECULIN BIOTECH INC - ANNAMYCIN CONTINUES TO BE 100%
NON-CARDIOTOXIC
    * MOLECULIN BIOTECH INC - ANNAMYCIN SHOWS CONSISTENT
EFFICACY IN
MULTIPLE CANCER MODELS

Source text for Eikon:  ID:nPn9t761za 
Further company coverage:  MBRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))